These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 7882380

  • 1. Anti-CD30 immunotoxins with native and recombinant dianthin 30.
    Bolognesi A, Tazzari PL, Legname G, Olivieri F, Modena D, Conte R, Stirpe F.
    Cancer Immunol Immunother; 1995 Feb; 40(2):109-14. PubMed ID: 7882380
    [Abstract] [Full Text] [Related]

  • 2. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice.
    Terenzi A, Bolognesi A, Pasqualucci L, Flenghi L, Pileri S, Stein H, Kadin M, Bigerna B, Polito L, Tazzari PL, Martelli MF, Stirpe F, Falini B.
    Br J Haematol; 1996 Mar; 92(4):872-9. PubMed ID: 8616080
    [Abstract] [Full Text] [Related]

  • 3. Targeting of type 1 ribosome-inactivating proteins to CD30+ or CD25+ hematologic neoplasias by bispecific antibodies.
    Sforzini S, Bolognesi A, Meazza R, Marciano S, Tazzari PL, Stein H, Stirpe F, Ferrini S.
    J Hematother; 1995 Oct; 4(5):429-32. PubMed ID: 8581380
    [Abstract] [Full Text] [Related]

  • 4. An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins.
    Tazzari PL, de Totero D, Bolognesi A, Testoni N, Pileri S, Roncella S, Reato G, Stein H, Gobbi M, Stirpe F.
    Haematologica; 1999 Nov; 84(11):988-95. PubMed ID: 10553158
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma.
    Pasqualucci L, Wasik M, Teicher BA, Flenghi L, Bolognesi A, Stirpe F, Polito L, Falini B, Kadin ME.
    Blood; 1995 Apr 15; 85(8):2139-46. PubMed ID: 7718885
    [Abstract] [Full Text] [Related]

  • 6. Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation.
    Tazzari PL, Bolognesi A, de Totero D, Falini B, Lemoli RM, Soria MR, Pileri S, Gobbi M, Stein H, Flenghi L.
    Br J Haematol; 1992 Jun 15; 81(2):203-11. PubMed ID: 1322690
    [Abstract] [Full Text] [Related]

  • 7. Nucleotide sequence of cDNA coding for dianthin 30, a ribosome inactivating protein from Dianthus caryophyllus.
    Legname G, Bellosta P, Gromo G, Modena D, Keen JN, Roberts LM, Lord JM.
    Biochim Biophys Acta; 1991 Aug 27; 1090(1):119-22. PubMed ID: 1840496
    [Abstract] [Full Text] [Related]

  • 8. Differential sensitivity of CD30+ neoplastic cells to gelonin delivered by anti-CD30/anti-gelonin bispecific antibodies.
    Sforzini S, Bolognesi A, Meazza R, Marciano S, Casalini P, Dürkop H, Tazzari PL, Stein H, Stirpe F, Ferrini S.
    Br J Haematol; 1995 Jul 27; 90(3):572-7. PubMed ID: 7646996
    [Abstract] [Full Text] [Related]

  • 9. Different sensitivity of CD30+ cell lines to Ber-H2/saporin-S6 immunotoxin.
    Battelli MG, Bolognesi A, Olivieri F, Polito L, Stirpe F.
    J Drug Target; 1998 Jul 27; 5(3):181-91. PubMed ID: 9606008
    [Abstract] [Full Text] [Related]

  • 10. In vivo and in vitro uptake of an anti-CD30/saporin immunotoxin by rat liver parenchymal and nonparenchymal cells.
    Battelli MG, Buonamici L, Bolognesi A, Stirpe F.
    Hepatology; 1994 Oct 27; 20(4 Pt 1):940-7. PubMed ID: 7927236
    [Abstract] [Full Text] [Related]

  • 11. Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin.
    Falini B, Bolognesi A, Flenghi L, Tazzari PL, Broe MK, Stein H, Dürkop H, Aversa F, Corneli P, Pizzolo G.
    Lancet; 1992 May 16; 339(8803):1195-6. PubMed ID: 1349939
    [Abstract] [Full Text] [Related]

  • 12. Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins.
    Bolognesi A, Tazzari PL, Olivieri F, Polito L, Falini B, Stirpe F.
    Int J Cancer; 1996 Nov 04; 68(3):349-55. PubMed ID: 8903477
    [Abstract] [Full Text] [Related]

  • 13. Targeting of saporin to Hodgkin's lymphoma cells by anti-CD30 and anti-CD25 bispecific antibodies.
    Sforzini S, de Totero D, Gaggero A, Ippoliti R, Glennie MJ, Canevari S, Stein H, Ferrini S.
    Br J Haematol; 1998 Sep 04; 102(4):1061-8. PubMed ID: 9734659
    [Abstract] [Full Text] [Related]

  • 14. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE, Brown AN, Bremner JA, Foxwell BM, Stirpe F.
    J Natl Cancer Inst; 1985 Jul 04; 75(1):151-9. PubMed ID: 3859688
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dianthins, ribosome-damaging proteins with anti-viral properties from Dianthus caryophyllus L. (carnation).
    Stirpe F, Williams DG, Onyon LJ, Legg RF, Stevens WA.
    Biochem J; 1981 May 01; 195(2):399-405. PubMed ID: 7316958
    [Abstract] [Full Text] [Related]

  • 17. B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells.
    Bregni M, Siena S, Formosa A, Lappi DA, Martineau D, Malavasi F, Dorken B, Bonadonna G, Gianni AM.
    Blood; 1989 Feb 15; 73(3):753-62. PubMed ID: 2465042
    [Abstract] [Full Text] [Related]

  • 18. A comparison of anti-lymphocyte immunotoxins containing different ribosome-inactivating proteins and antibodies.
    Bolognesi A, Tazzari PL, Tassi C, Gromo G, Gobbi M, Stirpe F.
    Clin Exp Immunol; 1992 Sep 15; 89(3):341-6. PubMed ID: 1516253
    [Abstract] [Full Text] [Related]

  • 19. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates.
    Letvin NL, Goldmacher VS, Ritz J, Yetz JM, Schlossman SF, Lambert JM.
    J Clin Invest; 1986 Mar 15; 77(3):977-84. PubMed ID: 3081579
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.